Clinical trial
Hypoxia-PET and IMPT Dose Painting in Patients With Chordomas: A Pilot Study
NCT00713037 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hypoxia-PET and IMPT Dose Painting in Patients With Chordomas: A Pilot Study
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- June 30, 2016
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.